Gerresheimer (GRRMF) Set to Announce Earnings on Wednesday

Gerresheimer (OTCMKTS:GRRMF) is anticipated to announce its results before the market opens on Wednesday, November 4th. Analysts expect Gerresheimer to post earnings of $0.2854 per share and revenue of $671.16 million for the quarter.

Gerresheimer Price Performance

Shares of GRRMF opened at $37.47 on Wednesday. The stock has a 50-day moving average of $31.38 and a two-hundred day moving average of $29.60. Gerresheimer has a one year low of $19.16 and a one year high of $37.47.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the company. UBS Group upgraded Gerresheimer from a “sell” rating to a “neutral” rating in a research note on Tuesday, August 4th. Sanford C. Bernstein raised Gerresheimer from an “underperform” rating to a “market perform” rating in a report on Wednesday, July 1st. Finally, Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Gerresheimer in a report on Tuesday, August 4th. Four investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Reduce”.

About Gerresheimer

Gerresheimer AG is a Germany-based manufacturer of packaging and drug-delivery systems for the pharmaceutical, biotechnology and cosmetics industries. The company develops and produces glass and plastic packaging, including vials, ampoules, syringes, cartridges, bottles and other containers used to store and administer medicines and other sensitive products.

Its portfolio also includes medical devices and drug-delivery solutions such as prefillable syringes, inhalers, pens and other injection-related systems.